Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brain and Hormone Therapy after Menopause
RBR-6nr6hp5Recruiting
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Apr 2025
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Open-label trial of semaglutide + estradiol + progesterone in menopause (3 arms), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Started Apr 2025; status: recruiting.
02
Drugs
semaglutide + estradiol + progesterone
03
Conditions
menopause
Beyond the preview
Go deeper on RBR-6nr6hp5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-6nr6hp5.